Assenagon Asset Management S.A. Grows Stake in Teradyne, Inc. (NASDAQ:TER)

Assenagon Asset Management S.A. boosted its position in shares of Teradyne, Inc. (NASDAQ:TERFree Report) by 1,767.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 923,068 shares of the company’s stock after purchasing an additional 873,626 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Teradyne were worth $116,233,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Ashton Thomas Private Wealth LLC acquired a new position in shares of Teradyne during the 2nd quarter worth approximately $27,000. Capital Performance Advisors LLP purchased a new position in Teradyne during the third quarter worth $29,000. Quarry LP increased its position in Teradyne by 256.1% during the second quarter. Quarry LP now owns 235 shares of the company’s stock worth $35,000 after buying an additional 169 shares in the last quarter. Coastline Trust Co acquired a new position in shares of Teradyne in the third quarter worth $46,000. Finally, Brooklyn Investment Group purchased a new stake in shares of Teradyne in the third quarter valued at $52,000. 99.77% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Teradyne

In other Teradyne news, CEO Gregory Stephen Smith sold 3,080 shares of the business’s stock in a transaction that occurred on Friday, January 3rd. The shares were sold at an average price of $130.00, for a total transaction of $400,400.00. Following the completion of the sale, the chief executive officer now directly owns 74,660 shares in the company, valued at $9,705,800. The trade was a 3.96 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.36% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

TER has been the subject of a number of recent research reports. JPMorgan Chase & Co. upgraded Teradyne from a “neutral” rating to an “overweight” rating and lifted their price objective for the stock from $145.00 to $158.00 in a research report on Monday, December 16th. Stifel Nicolaus lowered their price target on shares of Teradyne from $140.00 to $125.00 and set a “hold” rating for the company in a report on Friday, October 25th. Northland Capmk raised shares of Teradyne from a “hold” rating to a “strong-buy” rating in a research note on Monday, January 6th. Northland Securities upgraded shares of Teradyne from a “market perform” rating to an “outperform” rating and raised their target price for the stock from $117.00 to $154.00 in a research report on Monday, January 6th. Finally, Evercore ISI boosted their price target on Teradyne from $130.00 to $145.00 and gave the company an “overweight” rating in a report on Wednesday, October 9th. Three analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $150.33.

Read Our Latest Stock Report on TER

Teradyne Stock Up 0.7 %

Shares of NASDAQ TER opened at $134.18 on Wednesday. The stock has a market capitalization of $21.85 billion, a PE ratio of 42.60, a P/E/G ratio of 2.66 and a beta of 1.46. The firm has a fifty day moving average of $119.67 and a 200-day moving average of $127.22. Teradyne, Inc. has a 52-week low of $92.29 and a 52-week high of $163.21.

Teradyne (NASDAQ:TERGet Free Report) last posted its quarterly earnings results on Wednesday, October 23rd. The company reported $0.90 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.78 by $0.12. The firm had revenue of $737.30 million during the quarter, compared to the consensus estimate of $716.40 million. Teradyne had a return on equity of 18.56% and a net margin of 18.75%. The firm’s quarterly revenue was up 4.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.80 earnings per share. Equities research analysts expect that Teradyne, Inc. will post 3.17 EPS for the current fiscal year.

Teradyne announced that its Board of Directors has authorized a share repurchase program on Monday, November 11th that allows the company to buyback $100.00 million in shares. This buyback authorization allows the company to repurchase up to 0.6% of its shares through open market purchases. Shares buyback programs are often an indication that the company’s management believes its shares are undervalued.

Teradyne Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, December 18th. Investors of record on Monday, November 25th were given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 0.36%. The ex-dividend date of this dividend was Monday, November 25th. Teradyne’s dividend payout ratio (DPR) is presently 15.24%.

About Teradyne

(Free Report)

Teradyne, Inc designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.

See Also

Want to see what other hedge funds are holding TER? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teradyne, Inc. (NASDAQ:TERFree Report).

Institutional Ownership by Quarter for Teradyne (NASDAQ:TER)

Receive News & Ratings for Teradyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teradyne and related companies with MarketBeat.com's FREE daily email newsletter.